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Background: Dysregulation of apoptosis has been implicated in a range of diseases including tumors,
neurodegenerative and autoimmine diseases, as well as allergic asthma and chronic obstructive pulmonary disease
(COPD) in humans. Although it has a different pathophysiology, delayed apoptosis of various inflammatory cells
may play a pivotal role in the development of recurrent airway obstruction (RAO) in horses. Reduction of
inflammatory cell apoptosis or a dysregulation of this process could lead to chronic inflammation and tissue injury.
Therefore, the aim of this study was to investigate the rate of apoptosis and necrosis of neutrophils and
macrophages in bronchoalveolar lavage fluid obtained from seven horses suffering from RAO (study group) and
seven control horses.
Results: We demonstrated that neutrophil/macrophage apoptosis is altered in RAO-affected horses compared with
the control group in the BAL fluid. We found a significant difference between the median percentage of early and
late apoptosis of neutrophils between the study and control group of horses. Moreover, we found a positive
correlation between the rate of apoptosis and the median percentage of macrophages in RAO-affected horses.
Conclusion: The findings suggest that apoptosis dysregulation may play a significant role in the pathogenesis of
RAO. However, further studies are needed to clarify the role of altered apoptosis in the course of equine recurrent
airway obstruction.Background
Recurrent airway obstruction (RAO, “heaves”), also
known as ‘broken wind’, is an asthma-like condition that
develops in mature horses following stabling and expos-
ure to dusty hay and straw, affecting a large number of
animals worldwide. Affected horses develop airway
bronchoconstriction, neutrophilic inflammation and air-
way hyper-responsiveness. A number of environmental,
immunological, infectious and genetic factors play an
important role in the pathogenesis of RAO. However,
the immunological basis of the disease is still not
fully understood. The immediate-type I and the immune* Correspondence: artur.niedzwiedz@up.wroc.pl
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distribution, and reproduction in any mediumcomplex formation type III hypersensitivity reactions
play a pivotal role in the development of airway inflam-
mation. The most common clinical signs are cough ex-
acerbated after exercise or in dusty environments, nasal
discharge, exercise intolerance and respiratory difficulty
[1]. Pathological changes in the airways are present as a
result of neutrophilic inflammation, a mucous hyperse-
cretion and bronchospasm [2,3]. The degree of airway
obstruction may vary depending on the stage of the dis-
ease and can be reversed either by medication or a
change of the environment. Clinical signs as well as air-
way inflammation wane if RAO-affected horses remain
pastured for a prolonged time. Once the animals are
returned to the stable and dusty environment, breathing
problems relapse [4].
During an exacerbation of the disease in the in
RAO-affected horses, the cytological evaluation of thentral Ltd. This is an open access article distributed under the terms of the
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of nondegenerated segmented neutrophils (usually more
than 20%, in severe cases approximately 60-85%) com-
pared with that obtained from healthy horses, which
contains approximately 60% macrophages, 35% lympho-
cytes, <5% neutrophils and <2% mast cells [5].
Apoptosis is the process of programmed cell death
and is a highly ordered physiological process by which
irreversibly damaged or useless cells are eliminated
throughout one’s entire life. It consists of highly coordi-
nated molecular events leading to a sequence of mor-
phological changes and is accompanied by modifications
of the cellular surface. The cell loses its surface
anti-phagocytic signals and exposes ligands, such as
phosphatidylserine, designating the cell for phagocytosis.
Importantly, the early apoptotic cells preserve their
plasma membrane integrity to retain the potentially
harmful cellular contents inside. If not successfully taken
up by phagocytes, apoptotic cells proceed to the phase
of late apoptosis (also termed secondary necrosis), where
the plasma membrane becomes permeable to small mol-
ecules (e.g. propidium iodide (PI)) and, subsequently,
also macromolecules (proteins). Dysregulation of apop-
tosis has been implicated in a range of diseases including
tumors, neurodegenerative and autoimmune disorders,
as well as allergic asthma and COPD in humans [6-8].
This process has attracted great attention in horses in
recent years, and several studies concerning apoptosis of
different lymphocyte subpopulations in RAO-affected
horses have been conducted, since delays in the apop-
totic response may be associated with persistent inflam-
mation and subsequent tissue damage [9-11]. However,
to the authors’ knowledge, only limited research is avail-
able concerning the role of cell types other than lympho-
cytes in RAO affected horses [10,12]. Using fluorescence
microscopy, Breuer et al. found a significant increase in
the percentage of all necrotic cells in bronchoalveolar
lavage fluid (BALF) obtained from RAO-affected horses
compared to healthy controls. However, no difference
was found between the percentage of apoptotic and vi-
able BALF cells. In this study, the authors also used flow
cytometry to compare the percentage of necrotic, apop-
totic and viable cells with respect to cells with high
granularity, macrophages and lymphocytes. However,
due to relatively small groups of horses, the authors did
not conduct any statistical examination of the results
[10]. A study by Turlej et al. showed a significant delay
in the apoptosis of granulocytes obtained during bron-
choalveolar lavage in horses with heaves compared to
healthy horses, while the level of apoptosis of granulo-
cytes, obtained from the peripheral blood, was compar-
able between the two groups [12]. Additional knowledge
about the regulating mechanisms of apoptosis in all lung
cells would contribute to the better understanding of thepathophysiology of equine lung disorders and allow the
development of a targeted therapy.
Having hypothesized that the accumulation of neutro-
phils and macrophages in the airways of RAO-affected
horses can result from decreased apoptosis, the present
study was performed to quantify and characterize the apop-
tosis of airway neutrophils/macrophages recovered by
bronchoalveolar lavage from RAO-affected and healthy
horses.
Methods
This study was conducted with the approval of the 2nd
Local Ethics Committee concerning Animal Experimen-
tation in Wrocław (resolution No 1/2012).
Horses
Fourteen adult Polish Konik horses kept in uniform en-
vironmental and living conditions were used in this
study. Horses were qualified into the groups based on
their history. 7 horses were not affected by RAO (control
horses) and 7 horses had a history of RAO (RAO-
affected horses). All horses were owned by the Polish
Academy of Sciences Research Station for the Ecological
Agriculture and Preservation of Animal Breeding in
Popielno (latitude 53˚75′ N, longitude 21˚62′ E). The
control group consisted of five castrated males (geldings)
and two mares, whose ages ranged from 5-13 years
(mean ± SD, 7.7 ± 2.9), their body weights ranged from
350 to 400 kg and they measured approximately 110–
130 cm at the withers). The study group consisted of
four geldings and three mares. Their ages ranged from
7-14 years (mean ± SD, 9.8 ± 2.6), their body weights
varied between 350 and 400 kg, they measured approxi-
mately. 110–130 cm at the withers. and had a history of
chronic respiratory disease following exposure to moldy
hay and/or a dusty environment (RAO).
Experimental protocol
Prior to the study, all horses were kept on a pasture or
in a stable with wood shavings for a minimum of 8
weeks to ensure the RAO-affected horses were in
complete clinical remission. An acute crisis of heaves in
suitable animals was induced by placing all horses in a
poorly ventilated stable, bedding them on straw and
feeding them hay with visible mold growth for 48 hours
prior to examination. Hay and straw were not shaken up
additionally, since the introduction of the horses into
the poorly ventilated stable has been shown to suffice in
inducing airway inflammation and RAO exacerbation in
selected horses [11]. An inflammatory response to the
poor environmental conditions was confirmed using a
clinical RAO score, an endoscopic examination and
bronchoalveolar lavage fluid (BALF) cytology, arterial
blood gas analysis and venous blood samplings [13,14].
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Horses underwent only one full clinical examination
after a period of 48 h of dust exposure, including a visual
inspection, measurement of the internal rectal body
temperature, pulse and respiratory rate, evaluation of the
appearance of mucous membranes, auscultation of the
heart, intestinal peristalsis and recording of the capillary
refill time (CRT). The clinical RAO score, assessing the
condition of the respiratory system based on a cough
score, nostril flare and abdominal lift, was performed ac-
cording to guidelines previously described by Robinson
et al. [15]. Venous blood was collected from the external
jugular vein for hematology, screening biochemistry and
the analysis of acute phase proteins [14]. Samples were
maintained on ice immediately after collection and ana-
lyzed within 6 hours.
Arterial blood gas analysis
Arterial blood was collected anaerobically into heparin-
ized syringes through an arterial puncture of the facial
artery using an 18G butterfly needle. The blood was im-
mediately analyzed for the partial pressure of oxygen
and carbon dioxide (PaO2 and PaCO2) with the use of
an OPTI CCA-TS (OPTI Medical Systems, Inc., Roswell,
GA, USA) blood gas analyzer. Horses were identified as
healthy, if their PaO2 ≥ 90 mmHg, while horses with a
relapse of RAO had to have a PaO2 ≤ 85 mmHg [16,17].
Endoscopic examination, bronchoalveolar lavage fluid
collection and cytology
Horses were sedated with 0.01 mg/kg of detomidine
(Domosedan®, Orion Corporation, Finland) and 0.01 mg/kg
of butorphanol (Butomidor®, Richter Pharma AG, Austria)
prior to an endoscopy of the airways and a bronchoalveolar
lavage. A twitch had to be additionally used in some horses.
A 1.8 m long endoscope (Karl Storz) was then passed
through the nasal passage and trachea until it was wedged
in the right dorsocaudal lung lobe. Videos and pictures
were recorded and changes in the airways were graded by
two clinicians according to the quantity and quality of the
mucus, using a modified RAO staging scale previously de-
scribed by Tilley et al. [18] (see Additional file 1: Table S1).
Bronchoalveolar lavage was performed by instilling 250 ml
of sterile saline (0.9% NaCl) at body temperature through
the endoscope working channel into a bronchus using suc-
cessive 60 ml boluses, and reaspirating BALF through gen-
tle suction using a 60 ml syringe until no further fluid was
obtained [19]. The amount of reaspirated fluid was re-
corded and BALF was pooled in a sterile specimen cup
without any medium, placed on ice and processed within 2
hours after collection for each individual horse.
10 ml sample aliquots were cytospinned at 300 × g for
10 min using the Beckman Coulter Allegra ×-22 cytos-
pin and stained with Wright’s stain in order to makesmears. A 400-cell leukocyte differential count (×1000
magnification) was performed wherein epithelial cells
were not taken into account [20].
Staining for the evaluation of apoptosis
The Southern Biotech (Birmingham, AL 35209, USA)
ApoScreen™ Annexin V Apoptosis Kit was used. Prior to
staining, cells were concentrated to 1 × 106 to 1 × 107
cells/ml. A Vi-Cell XR (Beckman Coulter) was used to
assess the cell concentration. Cells were washed in cold
PBS twice, after which PBS was removed from the cell
pellet. Next, the cells were washed in 1 mL of 1×
Annexin V binding buffer once. The supernatants were
removed by centrifugation and the cells were suspended
in 1× Annexin V binding buffer. 10 μL of FITC-
conjugated Annexin V and 10 μL of propidium iodide
(PI) were added to the cells. They were then mixed gen-
tly and incubated for 15 min on ice in the dark, then di-
luted with 380 μL of 1× Annexin V binding buffer and
analyzed by flow cytometry within 1 h [21,22].
FACS acquisition and analysis
Flow cytometry analysis was performed using a FACS-
Canto II cytometer (BD Biosciences). The data were ac-
quired using version 6.1.3 of the FACSDiva software (BD
Biosciences) and analyzed using FlowJo software (Tree
Star Inc., Stanford, CA, USA). The cytometry setup and
tracking beads (CST, BD Biosciences) were used to
initialize PMT settings. Unstained control cells and a
single stain control for each fluorochrome were prepared
and used to set up flow cytometric compensation. Be-
tween 15,000 and 20,000 gated cells were analyzed.
Apoptosis was assessed in the total macrophage and
neutrophil population by the surface exposures of
plasma membrane phosphatidyl serine (Annexin V+cells)
and loss of plasma membrane integrity (PI+cells). A
macrophage and neutrophil region were established
according to their different light-scattering properties:
forward scatter (FSC) which reflects cell size, and side
scatter (SSC), which depends on the intensity and
diffraction capacity of the cells (complexity/granularity)
[23,24]. The dot plot of Annexin V versus PI was
used for the assessment of apoptosis. Annexin V-/PI-
cells were considered viable; Annexin V+/PI- cells
were deemed early-apoptotic; and double positive cells
(Annexin V+/PI+) were considered to be a mixture of
late apoptotic and primary necrotic cells (Figure 1).
Statistical analysis
Analysis using the Anderson Darling test indicated
that data were not distributed normally. The median,
25th and 75th percentiles are presented. The non-
parametric U Mann-Whitney test was performed to
evaluate the results. This analysis was performed
AB
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Figure 1 Examples of dot plot cytograms showing percentages of early apoptotic (Annexin V+PI-), late apoptotic/necrotic (Annexin V+PI+)
and viable (Annexin V-PI-) neutrophils/macrophages in normal control (A) and RAO-affected horses (B). Left pictures shows gating process to
obtain only neutrophile and macrophages region. Lymphocytes and epithelial cells were excluded from gating.
Table 1 Results of BAL fluid cytology, clinical assessment
and blood gas analysis in healthy horses and RAO-
affected horses
Healthy n=7 RAO-affected n=7
Clinical scorea 2.0 (2 and 2) 6 (5 and 6)
PaO2 (mmHg)a 91 (85 and 107) 96 (91 and 108)
PaCO2 (mmHg)b 45 (43 and 46) 45.5 (44 and 50)
BALF neutrophils (%)a 5.1 (4.1 and 5.3) 59.8 (51.3 and 64.8)
BALF lymphocytes (%)a 41 (38.5 and 45.9) 38.1 (34.8 and 41.1)
BALF macrophages (%)a 55.8 (49.8 and 59.1) 32.8 (25.9 and 35.7)
BALF eosinophils (%)a 0.4 (0.2 and 0.5) 0 (0 and 0)
BALF mast cells (%)b 0.1 (0 and 0.3) 0 (0 and 0)
Values are expressed as median and 25th and 75th percentiles.
aDifferences statistically significant (P < 0.05).
bNS.
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Tulsa, OK, USA). P < 0.05 was considered as statisti-
cally significant.
Results
Bronchoalveolar lavage cytology and clinical score
The bronchoalveolar lavage fluid cytology results, clin-
ical assessment and blood gas analysis are summarized
in Table 1. Based on these findings and the history of
each horse, control horses were considered healthy and
respiratory diseases free when they obtained a total clin-
ical RAO score of less than 1, and their BALF cytology
count showed less than 10% of neutrophils. Although
reference ranges of the percentage of neutrophils in
BALF of healthy horses are <5%, we considered the neu-
trophil count of <10% as a normal result, since stabling
in a dusty environment has been shown to increase the
neutrophil percentage in the BALF of healthy horses
[25]. However, the median percentage of neutrophils in
the control group was 5.1%. Horses from the RAO-
affected group had a history of episodes of RAO and
their total clinical RAO score was greater than or equal
to 5, and they had more than 20% neutrophils in their
BALF cytology. The mucus scores were generally low in
the control horses and, apart from mucus accumulation,all median variables in this group were below 1. Only
two individuals from this group had a mucous score of
2, while the remaining horses had a very small amount
of mucus or none at all. There was a statistically signifi-
cant difference (p < 0.05) between all endoscopic exam-
ination variables, when comparing the control and study
group. In the study group, all median variables were
above 2 and above 3 with regards to mucus viscosity.
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(p < 0.001) between both groups and was 56.6% (56.6 ± 9.9)
in the control horses, and 43.6% (43.6 ± 12.6) in the RAO-
affected horses. The median and ranges of the BALF
differential cell count in the control horses were as follows:
56.4 ± 9.5 macrophages, 42.1 ± 8.9 lymphocytes and 4.8 ±
2.3 neutrophils. In the RAO-affected horses, they amounted
to 28.4 ± 11.2 macrophages, 38.9 ± 12.4 lymphocytes and
58.9 ± 7.9 neutrophils. The mean percentage of neutrophils
was significantly higher in the group of RAO-affected
horses when compared to the healthy control group
(p < 0.001), whereas the mean percentage of macrophages
was significantly higher in the control group compared to
the RAO-affected horses (p < 0.001). The percentage of
lymphocytes in the group of healthy horses was also signifi-
cantly higher compared to the group of RAO-affected
horses (p < 0.05).
Neutrophil and macrophage apoptosis
The summarized results of the apoptosis of neutrophils and
macrophages are shown in Table 2. There was a significant
difference (p < 0.05) between the median percentage of
viable neutrophils obtained from the control group
(median = 85.9%, 25th and 75th percentiles = 76.7 and 92.2)
and that from the group of the RAO-affected horses
(median = 89.5%, 25th and 75th percentiles = 78.9 and
91.3). The BALF neutrophils obtained from the RAO-
affected horses were less AnnexinV+/PI- (early apoptotic)
than those from the control subjects (median 5.19% 25th
and 75th percentiles, 3.48 and 6.33 versus 12.3% 25th and
75th percentiles 4.69 and 19.8, respectively, p < 0.05). The
median percentage of AnnexinV+/PI+(late apoptotic) neu-
trophils was higher in the control group than in the RAO-
affected horses (4.7%, 25th and 75th percentiles, 2.96 and
3.94 and 4.09%, 25th and 75th percentiles 3.88 and 6.4, re-
spectively, p < 0.05), as shown in Table 2.
The percentage of viable macrophages from the
healthy controls (median = 83%, 25th and 75th percen-
tiles, 78.7 and 92.3) was higher compared to those from
RAO-affected individuals (median = 81.1%, 25th and
75th percentiles, 71.5 and 85.7), however no statistical
differences were observed. In contrast to neutrophils,
the median BALF macrophages from RAO-affected
horses were more AnnexinV+/PI- than those from theTable 2 The results are expressed as a percentage of viable, e







Healthy 85.9 (76.7 and 92.2) 12.3 (4.69 and 19.8) 4.7 (2.96 and
RAO-affected 89.5 (78.9 and 91.3) 5.19 (3.48 and 6.33) 4.09 (3.88 an
Values are expressed as median and 25th and 75th percentiles.
aDifferences statistically significant (P < 0.05).
bNS.healthy controls (4.2%, 25th and 75th percentiles,3.51
and 6.09 versus 3.53% 25th and 75th percentiles, 3.5 and
4.89 respectively, p < 0.05). Moreover, the median per-
centage of AnnexinV+/PI+macrophages was higher in
the group of RAO-affected horses compared to healthy
controls (12.7% 25th and 75th percentiles, 8.82 and
23.6and 10.8% 25th and 75th percentiles, 4.14 and 17.6,
respectively, p < 0.05).
Discussion
In our study, two groups of horses were evaluated and
compared with regard to several variables of the respira-
tory system. The experimental protocol included sample
collection and the examination of results acquired from
healthy Polish Konik horses, and those suffering from
RAO. The results obtained in the study group (almost
60% of nondegenerated neutrophils) clearly demonstrate
RAO as a direct cause of a chronic respiratory problem.
It is interesting to note that the results obtained from
the control group are slightly above the reference ranges,
despite the fact that these horses were stabled in a dusty
barn for 48 h and fed poor quality, moldy hay. Our data
are inconsistent with results reported by Holcombe et al.
(2001), who showed that stabling is associated with air-
way inflammation and significant changes in the BAL
cytological profile [25]. The most likely explanation of
the slightly elevated percentage of neutrophils in the
control group in this study is that it was a response to
the stabling conditions. However, since baseline BAL re-
sults of the horses prior to stabling were not obtained,
this is only an assumption.
Several mechanisms contribute to the pathogenesis of
RAO in horses. First, inhalation of molds, dust or nox-
ious particles such as ammonium, cause the migration
and presence of inflammatory cells in the bronchi, lead-
ing to chronic inflammation [1]. Secondly, there is a dis-
ruption in mucous cell hyperplasia in RAO-affected
horses [12]. The third mechanism in the pathogenesis of
RAO involves oxidative stress and disturbances between
antioxidants and free radicals [26]. There may be
a fourth hypothetical mechanism involved in the patho-
genesis of the disease in horses, involving a disruption of
the balance between apoptosis and necrosis of the in-









3.94) 83.0 (78.7 and 92.3) 3.53 (3.5 and 4.89) 10.8 (4.14 and 17.6)
d 6.4) 81.1 (71.5 and 85.7) 4.2 (3.51 and 6.09) 12.7 (8.62 and 23.6)
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and other leukocytes in the lower airways can be
explained an increased neutrophil activation and chemo-
taxis [12,27] and a delayed tissue clearance due to de-
layed apoptosis or dysfunction in the clearance of these
cells. It has been proven that delayed apoptosis is associ-
ated with inflammatory diseases such as cystic fibrosis
and pneumonia and different types of neoplasm [6-8].
Moreover, similar findings have been demonstrated in
human asthma, where delayed apoptosis was seen in
peripheral blood eosinophils [6,28].
In the present study, we demonstrated that neutro-
phil/macrophage apoptosis is altered in RAO-affected
horses compared with the control group in BAL fluid.
The median percentage of viable neutrophils was sig-
nificantly higher in the RAO affected horses than in
the controls, suggesting that a higher percentage of
neutrophils can result from specific survival factors
at the site of inflammation. Previous studies have also
demonstrated delayed apoptosis of BALF neutrophils.
In a study by Turlej et al. BALF neutrophils from
RAO-affected horses demonstrated a significant delay
in apoptosis together with blood neutrophils from the
sick and healthy horses, in contrast to BALF neutro-
phils of control animals [12]. The rate of peripheral
blood neutrophil apoptosis was comparable, suggest-
ing that an enhanced survival of BALF neutrophils is
the result of the action of specific cytokines, which
affect granulocytes that have extravasated into the
inflamed lungs. A key contributing factor in delayed
apoptosis seems to be the granulocyte/macrophage
colony stimulating factor (GM-CSF) [29-31]. The local
concentration of GM-CSF is increased in airway dis-
eases characterized by an accumulation of neutrophils,
such as RAO in horses or, asthma in humans. It has
been shown that GM-CSF delays equine neutrophil
apoptosis by activating the STAT3 and STAT5 signal
transducer and activator of the (STAT) transcription
family members, which are critical regulators of the
expression of various Bcl-2 family proteins [12,29]. As
mentioned in the introduction, Breuer et al. did not
conduct a statistical analysis with respect to specific
leukocyte subpopulations. However there are appear
to be relatively high values between apoptotic and vi-
able cells with high granularity in the RAO-affected
horses. Despite the lack of a statistical comparison, it
seems that results of our study are comparable.
In our study, we found a significant difference between
the median percentage of early and late apoptosis occurring
within neutrophils in the study and control group of horses.
A higher proportion of early and late apoptotic neutrophils
can explain a lower number of these cells in general in the
lungs of healthy horses. Large numbers of apoptotic cells
are constantly generated in vivo and phagocytes such asmacrophages should remove apoptotic cells as soon as they
appear. However, it should be noted that late apoptotic cells
are phagocytized much more significantly than early apop-
totic cells, which can explain the large difference in median
percentages between early and late apoptotic neutrophils in
healthy horses.
Finally, in our study, we found a positive correlation be-
tween the rate of apoptosis and median percentage of mac-
rophages in the RAO-affected horses. . While there are two
reports on the rate of apoptosis of neutrophils, to the au-
thors’ knowledge there is only one study evaluating the
apoptosis of alveolar macrophages. However, it lacks a stat-
istical assessment [10,12]. Taking into consideration the re-
sults of this study, our observations are similar with the
numbers and medians of Breuer et al. except the necrotic
macrophages, [10]. Alveolar macrophages are an important
source of cytokines, which can participate in tissue damage.
However, cytokines can also influence the apoptotic death
of macrophages: macrophage apoptosis can be increased by
interferon-gamma and reduced by IL-4, IL-10 and TGF-b
[32]. Moreover, an increase in the early and late rate of
apoptosis in macrophages from RAO-affected horses can
explain a lower percentage of these cells in BALF obtained
from these animals compared with healthy controls.
This study has some limitations. Firstly, the sample
size is small. Although differences between the groups
are statistically significant, the data should be confirmed
by further controlled studies engaging a larger popula-
tion of horses. Secondly, we did not use special staining
methods to evaluate macrophages and neutrophils. Such
staining could help to better classify the cells.
Conclusion
In conclusion, the findings suggest that pulmonary neutro-
phil/macrophage apoptosis is altered in RAO in horses.
This disturbance plays an important role in the pathogen-
esis of allergic diseases both in humans and in horses. A de-
tailed study on the signaling pathway in lung granulocytes/
macrophages in RAO-affected horses can lead to a new
therapeutic approach to this disease. Therefore, more stud-
ies are needed to investigate apoptosis and its control
mechanism in the course of RAO in horses.
Additional file
Additional file 1: Table S1. Modified clinical staging of RAO in horses
according to Tilley et al. [18].
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